The study revealed that most ATM-associated breast tumours are luminal B or luminal B/HER2+ tumours, which is consistent with a recent case-control study showing that ATM TV carriers are at increased risk of developing ER+ breast tumours [39]. The gene discussed is ESR1; the disease is neoplasm.